ID   TLK1_HUMAN              Reviewed;         766 AA.
AC   Q9UKI8; B3KR15; B4DX87; Q14150; Q8N591; Q9NYH2; Q9Y4F6;
DT   22-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   22-AUG-2003, sequence version 2.
DT   12-OCT-2022, entry version 205.
DE   RecName: Full=Serine/threonine-protein kinase tousled-like 1;
DE            EC=2.7.11.1;
DE   AltName: Full=PKU-beta;
DE   AltName: Full=Tousled-like kinase 1;
GN   Name=TLK1; Synonyms=KIAA0137;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000312|EMBL:AAF03094.1};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Placenta {ECO:0000269|PubMed:9427565}, and Testis
RC   {ECO:0000269|PubMed:9427565};
RX   PubMed=9427565; DOI=10.1016/s0378-1119(97)00495-2;
RA   Yamakawa A., Kameoka Y., Hashimoto K., Yoshitake Y., Nishikawa K.,
RA   Tanihara K., Date T.;
RT   "cDNA cloning and chromosomal mapping of genes encoding novel protein
RT   kinases termed PKU-alpha and PKU-beta, which have nuclear localization
RT   signal.";
RL   Gene 202:193-201(1997).
RN   [2] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, MUTAGENESIS OF ASP-607,
RP   SUBCELLULAR LOCATION, INTERACTION WITH TLK2, AND ACTIVITY REGULATION.
RC   TISSUE=Placenta {ECO:0000312|EMBL:AAF03094.1};
RX   PubMed=10523312; DOI=10.1093/emboj/18.20.5691;
RA   Sillje H.H.W., Takahashi K., Tanaka K., Van Houwe G., Nigg E.A.;
RT   "Mammalian homologues of the plant tousled gene code for cell-cycle-
RT   regulated kinases with maximal activities linked to ongoing DNA
RT   replication.";
RL   EMBO J. 18:5691-5702(1999).
RN   [3] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), FUNCTION, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Placenta {ECO:0000269|PubMed:10588641};
RX   PubMed=10588641; DOI=10.1091/mbc.10.12.4033;
RA   Cabaniols J.-P., Ravichandran V., Roche P.A.;
RT   "Phosphorylation of SNAP-23 by the novel kinase SNAK regulates t-SNARE
RT   complex assembly.";
RL   Mol. Biol. Cell 10:4033-4041(1999).
RN   [4] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow {ECO:0000269|PubMed:8590280};
RX   PubMed=8590280; DOI=10.1093/dnares/2.4.167;
RA   Nagase T., Seki N., Tanaka A., Ishikawa K., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. IV. The
RT   coding sequences of 40 new genes (KIAA0121-KIAA0160) deduced by analysis of
RT   cDNA clones from human cell line KG-1.";
RL   DNA Res. 2:167-174(1995).
RN   [5]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4 AND 5).
RC   TISSUE=Amygdala, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [8] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus {ECO:0000312|EMBL:AAH32657.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   FUNCTION, INTERACTION WITH ASF1A AND ASF1B, AND MUTAGENESIS OF ASP-607.
RX   PubMed=11470414; DOI=10.1016/s0960-9822(01)00298-6;
RA   Sillje H.H.W., Nigg E.A.;
RT   "Identification of human Asf1 chromatin assembly factors as substrates of
RT   Tousled-like kinases.";
RL   Curr. Biol. 11:1068-1073(2001).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, AND PHOSPHORYLATION OF HISTONE H3.
RX   PubMed=11314006; DOI=10.1038/sj.onc.1204147;
RA   Li Y., DeFatta R., Anthony C., Sunavala G., De Benedetti A.;
RT   "A translationally regulated Tousled kinase phosphorylates histone H3 and
RT   confers radioresistance when overexpressed.";
RL   Oncogene 20:726-738(2001).
RN   [11] {ECO:0000305}
RP   FUNCTION, MUTAGENESIS OF SER-743, PHOSPHORYLATION AT SER-743, AND ACTIVITY
RP   REGULATION.
RX   PubMed=12660173; DOI=10.1093/emboj/cdg151;
RA   Groth A., Lukas J., Nigg E.A., Sillje H.H.W., Wernstedt C., Bartek J.,
RA   Hansen K.;
RT   "Human tousled like kinases are targeted by an ATM- and Chk1-dependent DNA
RT   damage checkpoint.";
RL   EMBO J. 22:1676-1687(2003).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-159, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-159, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 (ISOFORM 3), AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-38; SER-54; SER-77 AND
RP   SER-159, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   VARIANT [LARGE SCALE ANALYSIS] CYS-121.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Rapidly and transiently inhibited by phosphorylation
CC       following the generation of DNA double-stranded breaks during S-phase.
CC       This is cell cycle checkpoint and ATM-pathway dependent and appears to
CC       regulate processes involved in chromatin assembly. Isoform 3
CC       phosphorylates and enhances the stability of the t-SNARE SNAP23,
CC       augmenting its assembly with syntaxin. Isoform 3 protects the cells
CC       from the ionizing radiation by facilitating the repair of DSBs. In
CC       vitro, phosphorylates histone H3 at 'Ser-10'.
CC       {ECO:0000269|PubMed:10523312, ECO:0000269|PubMed:10588641,
CC       ECO:0000269|PubMed:11314006, ECO:0000269|PubMed:11470414,
CC       ECO:0000269|PubMed:12660173, ECO:0000269|PubMed:9427565}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:10523312, ECO:0000269|PubMed:10588641,
CC         ECO:0000269|PubMed:9427565};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:10523312,
CC         ECO:0000269|PubMed:10588641, ECO:0000269|PubMed:9427565};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:10523312, ECO:0000269|PubMed:10588641,
CC         ECO:0000269|PubMed:9427565};
CC   -!- ACTIVITY REGULATION: Cell-cycle regulated, maximal activity in S-phase.
CC       Inactivated by phosphorylation at Ser-743, potentially by CHEK1.
CC       {ECO:0000269|PubMed:10523312, ECO:0000269|PubMed:12660173}.
CC   -!- SUBUNIT: Heterodimerizes with TLK2. Interacts with ASF1A and ASF1B.
CC       {ECO:0000269|PubMed:10523312, ECO:0000269|PubMed:11470414}.
CC   -!- INTERACTION:
CC       Q9UKI8; Q8N7W2-2: BEND7; NbExp=3; IntAct=EBI-740492, EBI-10181188;
CC       Q9UKI8; Q6PI77: BHLHB9; NbExp=3; IntAct=EBI-740492, EBI-11519926;
CC       Q9UKI8; Q7L190: DPPA4; NbExp=3; IntAct=EBI-740492, EBI-710457;
CC       Q9UKI8; Q96FJ2: DYNLL2; NbExp=4; IntAct=EBI-740492, EBI-742371;
CC       Q9UKI8; P50458: LHX2; NbExp=3; IntAct=EBI-740492, EBI-12179869;
CC       Q9UKI8; Q9P127: LUZP4; NbExp=3; IntAct=EBI-740492, EBI-10198848;
CC       Q9UKI8; P26367: PAX6; NbExp=3; IntAct=EBI-740492, EBI-747278;
CC       Q9UKI8; Q96BK5: PINX1; NbExp=3; IntAct=EBI-740492, EBI-721782;
CC       Q9UKI8; Q06124-2: PTPN11; NbExp=3; IntAct=EBI-740492, EBI-17635971;
CC       Q9UKI8; Q12800: TFCP2; NbExp=3; IntAct=EBI-740492, EBI-717422;
CC       Q9UKI8; Q5VU62: TPM3; NbExp=3; IntAct=EBI-740492, EBI-10184033;
CC       Q9UKI8; Q8IY57-5: YAF2; NbExp=3; IntAct=EBI-740492, EBI-12111538;
CC       Q9UKI8; Q8N720: ZNF655; NbExp=3; IntAct=EBI-740492, EBI-625509;
CC       Q9UKI8; Q6PK81: ZNF773; NbExp=3; IntAct=EBI-740492, EBI-2686307;
CC       Q9UKI8; Q3KNS6-3: ZNF829; NbExp=3; IntAct=EBI-740492, EBI-18036029;
CC       Q9UKI8; P10073: ZSCAN22; NbExp=3; IntAct=EBI-740492, EBI-10178224;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10523312,
CC       ECO:0000269|PubMed:10588641, ECO:0000269|PubMed:11314006,
CC       ECO:0000269|PubMed:9427565}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1 {ECO:0000269|PubMed:10523312};
CC         IsoId=Q9UKI8-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:9427565};
CC         IsoId=Q9UKI8-2; Sequence=VSP_050571;
CC       Name=3 {ECO:0000269|PubMed:10588641}; Synonyms=SNAK
CC       {ECO:0000269|PubMed:10588641}, TLK1B;
CC         IsoId=Q9UKI8-3; Sequence=VSP_050570;
CC       Name=4;
CC         IsoId=Q9UKI8-4; Sequence=VSP_043505, VSP_043506;
CC       Name=5;
CC         IsoId=Q9UKI8-5; Sequence=VSP_043504;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Present in fetal placenta, liver,
CC       kidney and pancreas but not heart or skeletal muscle. Also found in
CC       adult cell lines. Isoform 3 is ubiquitously expressed in all tissues
CC       examined. {ECO:0000269|PubMed:10588641, ECO:0000269|PubMed:9427565}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein
CC       kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF03094.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA09486.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB004885; BAA20562.1; -; mRNA.
DR   EMBL; AF162666; AAF03094.1; ALT_INIT; mRNA.
DR   EMBL; AF246219; AAF71263.1; -; mRNA.
DR   EMBL; D50927; BAA09486.2; ALT_INIT; mRNA.
DR   EMBL; AK090779; BAG52227.1; -; mRNA.
DR   EMBL; AK301857; BAG63299.1; -; mRNA.
DR   EMBL; AC007739; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC009953; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC010092; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC032657; AAH32657.1; -; mRNA.
DR   CCDS; CCDS2241.1; -. [Q9UKI8-1]
DR   CCDS; CCDS46447.1; -. [Q9UKI8-5]
DR   CCDS; CCDS46448.1; -. [Q9UKI8-4]
DR   RefSeq; NP_001130026.1; NM_001136554.1. [Q9UKI8-5]
DR   RefSeq; NP_001130027.1; NM_001136555.1. [Q9UKI8-4]
DR   RefSeq; NP_036422.3; NM_012290.4. [Q9UKI8-1]
DR   RefSeq; XP_016860910.1; XM_017005421.1.
DR   RefSeq; XP_016860911.1; XM_017005422.1. [Q9UKI8-3]
DR   AlphaFoldDB; Q9UKI8; -.
DR   SMR; Q9UKI8; -.
DR   BioGRID; 115206; 51.
DR   IntAct; Q9UKI8; 39.
DR   MINT; Q9UKI8; -.
DR   STRING; 9606.ENSP00000411099; -.
DR   BindingDB; Q9UKI8; -.
DR   ChEMBL; CHEMBL5388; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; Q9UKI8; -.
DR   iPTMnet; Q9UKI8; -.
DR   PhosphoSitePlus; Q9UKI8; -.
DR   BioMuta; TLK1; -.
DR   DMDM; 34223086; -.
DR   EPD; Q9UKI8; -.
DR   jPOST; Q9UKI8; -.
DR   MassIVE; Q9UKI8; -.
DR   MaxQB; Q9UKI8; -.
DR   PaxDb; Q9UKI8; -.
DR   PeptideAtlas; Q9UKI8; -.
DR   PRIDE; Q9UKI8; -.
DR   ProteomicsDB; 84791; -. [Q9UKI8-1]
DR   ProteomicsDB; 84792; -. [Q9UKI8-2]
DR   ProteomicsDB; 84793; -. [Q9UKI8-3]
DR   ProteomicsDB; 84794; -. [Q9UKI8-4]
DR   ProteomicsDB; 84795; -. [Q9UKI8-5]
DR   Antibodypedia; 19345; 394 antibodies from 34 providers.
DR   DNASU; 9874; -.
DR   Ensembl; ENST00000360843.7; ENSP00000354089.3; ENSG00000198586.14. [Q9UKI8-2]
DR   Ensembl; ENST00000431350.7; ENSP00000411099.2; ENSG00000198586.14. [Q9UKI8-1]
DR   Ensembl; ENST00000434911.6; ENSP00000409222.2; ENSG00000198586.14. [Q9UKI8-4]
DR   Ensembl; ENST00000521943.5; ENSP00000428113.1; ENSG00000198586.14. [Q9UKI8-5]
DR   GeneID; 9874; -.
DR   KEGG; hsa:9874; -.
DR   MANE-Select; ENST00000431350.7; ENSP00000411099.2; NM_012290.5; NP_036422.3.
DR   UCSC; uc002ugn.3; human. [Q9UKI8-1]
DR   CTD; 9874; -.
DR   DisGeNET; 9874; -.
DR   GeneCards; TLK1; -.
DR   HGNC; HGNC:11841; TLK1.
DR   HPA; ENSG00000198586; Low tissue specificity.
DR   MIM; 608438; gene.
DR   neXtProt; NX_Q9UKI8; -.
DR   OpenTargets; ENSG00000198586; -.
DR   PharmGKB; PA36543; -.
DR   VEuPathDB; HostDB:ENSG00000198586; -.
DR   eggNOG; KOG1151; Eukaryota.
DR   GeneTree; ENSGT00950000182984; -.
DR   InParanoid; Q9UKI8; -.
DR   OMA; YKHACRE; -.
DR   OrthoDB; 693214at2759; -.
DR   PhylomeDB; Q9UKI8; -.
DR   TreeFam; TF315233; -.
DR   PathwayCommons; Q9UKI8; -.
DR   SignaLink; Q9UKI8; -.
DR   SIGNOR; Q9UKI8; -.
DR   BioGRID-ORCS; 9874; 27 hits in 1114 CRISPR screens.
DR   ChiTaRS; TLK1; human.
DR   GeneWiki; TLK1; -.
DR   GenomeRNAi; 9874; -.
DR   Pharos; Q9UKI8; Tchem.
DR   PRO; PR:Q9UKI8; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q9UKI8; protein.
DR   Bgee; ENSG00000198586; Expressed in lateral nuclear group of thalamus and 207 other tissues.
DR   ExpressionAtlas; Q9UKI8; baseline and differential.
DR   Genevisible; Q9UKI8; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IEA:UniProtKB-KW.
DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.
DR   GO; GO:0007059; P:chromosome segregation; IBA:GO_Central.
DR   GO; GO:0006886; P:intracellular protein transport; IDA:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:UniProtKB.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:1902275; P:regulation of chromatin organization; IDA:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; ATP-binding; Cell cycle;
KW   Chromatin regulator; Coiled coil; DNA damage; Kinase; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..766
FT                   /note="Serine/threonine-protein kinase tousled-like 1"
FT                   /id="PRO_0000086752"
FT   DOMAIN          456..734
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..197
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          346..383
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          230..281
FT                   /evidence="ECO:0000255"
FT   COILED          397..445
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        1..31
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        44..63
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        70..106
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        107..131
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        169..190
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        351..370
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        586
FT                   /note="Proton acceptor"
FT   BINDING         462..470
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         485
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         38
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         54
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         77
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         80
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8C0V0"
FT   MOD_RES         134
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86UE8"
FT   MOD_RES         159
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163"
FT   MOD_RES         174
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86UE8"
FT   MOD_RES         176
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86UE8"
FT   MOD_RES         743
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:12660173"
FT   VAR_SEQ         1..217
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10588641"
FT                   /id="VSP_050570"
FT   VAR_SEQ         1..48
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_043504"
FT   VAR_SEQ         1..14
FT                   /note="MSVQSSSGSLEGPP -> MAVLFLYDLKTTGK (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_043505"
FT   VAR_SEQ         15..110
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_043506"
FT   VAR_SEQ         136
FT                   /note="G -> GFPNLPVFQSLAYWEMGRTAGG (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9427565"
FT                   /id="VSP_050571"
FT   VARIANT         121
FT                   /note="R -> C"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041215"
FT   MUTAGEN         607
FT                   /note="D->A: Loss of kinase activity."
FT                   /evidence="ECO:0000269|PubMed:10523312,
FT                   ECO:0000269|PubMed:11470414"
FT   MUTAGEN         743
FT                   /note="S->A: Loss of kinase inhibition in response to DNA
FT                   damage."
FT                   /evidence="ECO:0000269|PubMed:12660173"
FT   MUTAGEN         743
FT                   /note="S->D: Loss of kinase inhibition in response to DNA
FT                   damage."
FT                   /evidence="ECO:0000269|PubMed:12660173"
FT   MUTAGEN         743
FT                   /note="S->E: Loss of kinase inhibition in response to DNA
FT                   damage."
FT                   /evidence="ECO:0000269|PubMed:12660173"
FT   CONFLICT        88
FT                   /note="S -> T (in Ref. 2; AAF03094)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        102
FT                   /note="G -> E (in Ref. 1; BAA20562)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        230
FT                   /note="Q -> L (in Ref. 1; BAA20562)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        261
FT                   /note="E -> D (in Ref. 1; BAA20562)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        416
FT                   /note="E -> G (in Ref. 1; BAA20562)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        439
FT                   /note="N -> H (in Ref. 1; BAA20562)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        471
FT                   /note="Y -> D (in Ref. 1; BAA20562)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        477
FT                   /note="Y -> S (in Ref. 1; BAA20562)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        625
FT                   /note="D -> V (in Ref. 1; BAA20562)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        665
FT                   /note="F -> Y (in Ref. 1; BAA20562)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        730
FT                   /note="N -> C (in Ref. 1; BAA20562)"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         Q9UKI8-3:1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
SQ   SEQUENCE   766 AA;  86700 MW;  A65AE0A2A7C7FF2F CRC64;
     MSVQSSSGSL EGPPSWSQLS TSPTPGSAAA ARSLLNHTPP SGRPREGAMD ELHSLDPRRQ
     ELLEARFTGV ASGSTGSTGS CSVGAKASTN NESSNHSFGS LGSLSDKESE TPEKKQSESS
     RGRKRKAENQ NESSQGKSIG GRGHKISDYF EYQGGNGSSP VRGIPPAIRS PQNSHSHSTP
     SSSVRPNSPS PTALAFGDHP IVQPKQLSFK IIQTDLTMLK LAALESNKIQ DLEKKEGRID
     DLLRANCDLR RQIDEQQKLL EKYKERLNKC ISMSKKLLIE KSTQEKLSSR EKSMQDRLRL
     GHFTTVRHGA SFTEQWTDGF AFQNLVKQQE WVNQQREDIE RQRKLLAKRK PPTANNSQAP
     STNSEPKQRK NKAVNGAEND PFVRPNLPQL LTLAEYHEQE EIFKLRLGHL KKEEAEIQAE
     LERLERVRNL HIRELKRINN EDNSQFKDHP TLNERYLLLH LLGRGGFSEV YKAFDLYEQR
     YAAVKIHQLN KSWRDEKKEN YHKHACREYR IHKELDHPRI VKLYDYFSLD TDTFCTVLEY
     CEGNDLDFYL KQHKLMSEKE ARSIVMQIVN ALRYLNEIKP PIIHYDLKPG NILLVDGTAC
     GEIKITDFGL SKIMDDDSYG VDGMDLTSQG AGTYWYLPPE CFVVGKEPPK ISNKVDVWSV
     GVIFFQCLYG RKPFGHNQSQ QDILQENTIL KATEVQFPVK PVVSSEAKAF IRRCLAYRKE
     DRFDVHQLAN DPYLLPHMRR SNSSGNLHMA GLTASPTPPS SSIITY
//
